According to the importance of positron emitters in nuclear medicine, 82mRb was produced as a member of this group of radiopharmaceuticals. After being converted into an injectable form, enough information was provided for imaging with this radiopharmaceutical. 82mRb with high radioisotopic purity and half-life of 6.5 hours, in chloride form, can be considered as a suitable positron emitter for the assessment of myocardial function. As a result of the bombardment of 82Kr with 15.4 MeV protons, the activity of 35.04 mCi was finally achieved. The nuclear reaction efficiency was 6.37 mCi/μAh. The product had a high radiopharmaceutical purity, according to international standards.